Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 727 to 776 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
364\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
luc7-like 2; cgi-74 protein; cgi-59 protein. [source:refseq;acc:nm\_016019]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8129.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05423\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5189\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
365\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 26, member 9 isoform b; anion transporter/exchanger-9. [source:refseq;acc:nm\_134325]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8452.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8910.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05419\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
366\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crooked neck-like protein 1 (crooked neck homolog) (hcrn) (cgi-201) (mstp021). [source:swissprot;acc:q9bzj0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prestin. [source:swissprot;acc:p58743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8452.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8910.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05419\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
367\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l21. [source:swissprot;acc:p46778]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon, catalytic subunit a (ec 2.7.7.7) (dna polymerase ii subunit a). [source:swissprot;acc:q07864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4024.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4719.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17268\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
368\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pendrin (sodium-independent chloride/iodide transporter). [source:swissprot;acc:o43511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8452.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8910.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05419\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna splicing factor prp17 (hprp17) (eh-binding protein 3) (ehb3). [source:swissprot;acc:o60508]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5082.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5959.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17261\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
369\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-box-binding transcription factor (ccaat-binding factor) (cbf). [source:swissprot;acc:q03701]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3583.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4194.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17061\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 26 member 6 (pendrin-like protein 1) (pendrin l1). [source:swissprot;acc:q9bxs9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8452.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8910.99\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05419\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
370\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
luc7-like; sarcoplasmic reticulum protein luc7b1. [source:refseq;acc:nm\_018032]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7708.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8125.74\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4108.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4808.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17058\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
371\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5067.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5926.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16961\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synbindin (trs23 homolog) (hematopoietic stem/progenitor cell protein 172) (hspc172) (ptd009) (cgi-104). [source:swissprot;acc:q9y296]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8551.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9014.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05417\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
372\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
au rna-binding protein/enoyl-coenzyme a hydratase precursor; au rna-binding protein/enoyl-coenzyme a hydratase; 3-methylglutaconyl-coa hydratase; mga type i. [source:refseq;acc:nm\_001698]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7799.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8221.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05415\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5926.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16956\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
373\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5066.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5926.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16955\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secreted modular calcium-binding protein 1. [source:refseq;acc:nm\_022137]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7633.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8043.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05374\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
374\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 1. [source:swissprot;acc:o60925]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5066.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5925.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16942\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
375\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
secreted modular calcium-binding protein 2; smooth muscle associated protein 2. [source:refseq;acc:nm\_022138]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7633.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8043.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05374\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm1 (small nuclear ribonuclear casm) (cancer-associated sm-like). [source:swissprot;acc:o15116]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4700.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5492.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16854\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
376\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
44050 protein. [source:refseq;acc:nm\_178832]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17385.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14889.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16769\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
choline dehydrogenase. [source:refseq;acc:nm\_018397]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7633.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8043.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05374\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidyl-trna synthetase homolog (ec 6.1.1.21) (histidine--trna ligase homolog) (hisrs). [source:swissprot;acc:p49590]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8724.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9193.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05372\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear inhibitor of protein phosphatase-1 (nipp-1) (protein phosphatase 1, regulatory inhibitor subunit 8) [includes: activator of rna decay (ec 3.1.4.-) (ard-1)]. [source:swissprot;acc:q12972]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17385.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14889.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16769\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ceramide glucosyltransferase (ec 2.4.1.80) (glucosylceramide synthase) (gcs) (udp-glucose:n-acylsphingosine d-glucosyltransferase) (glct-1). [source:swissprot;acc:q16739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8722.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9190.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05365\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16758\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 5 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 5) (fmo 5) (dimethylaniline oxidase 5). [source:swissprot;acc:p49326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7625.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8034.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05362\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6704.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7811.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16512\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
380\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
12998.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15138.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16461\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily c member 8 (splicing protein spf31) (hspc315). [source:swissprot;acc:o75937]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6760.17\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7122.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05362\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
381\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c3hc4-type zinc finger protein; likely ortholog of mouse dioxin inducible factor 3. [source:refseq;acc:nm\_024835]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5246.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6109.31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16456\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
382\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidyl-trna synthetase (ec 6.1.1.21) (histidine--trna ligase) (hisrs). [source:swissprot;acc:p12081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8721.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9188.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
parkinson disease (autosomal recessive, juvenile) 2, parkin isoform 1; parkin. [source:refseq;acc:nm\_004562]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
383\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7115.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7496.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05356\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
384\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgi-142; hepatoma-derived growth factor 2. [source:refseq;acc:nm\_016073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-3 (iroquois homeobox protein 3) (fragment). [source:swissprot;acc:p78415]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8964.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9443.02\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05338\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
385\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-1 (iroquois homeobox protein 1) (fragment). [source:swissprot;acc:p78414]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8964.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9442.82\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
386\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8159.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8594.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05337\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
387\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor (hdgf) (high-mobility group protein 1- like 2) (hmg-1l2). [source:swissprot;acc:p51858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-5 (iroquois homeobox protein 5) (irx-2a). [source:swissprot;acc:p78411]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8966.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9444.64\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05336\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
388\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-2 (iroquois homeobox protein 2) (fragment). [source:swissprot;acc:q9bzi1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8966.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9445.26\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/